Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

So in mono , Final Results after 10 weeks , 525 w

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154868
(Total Views: 302)
Posted On: 11/10/2019 2:34:48 PM
Avatar
Posted By: trding
Re: misiu143 #10693
Quote:
So in mono ,
Final Results after 10 weeks , 525 were 95%’
And 700 mg upper 80,s or 90%,
And with time they changed for 700 mg to 92%...



I separated my response post into two for length. The FDA requested for mono in their letter to cydy after the phase 2 trial, that cydy find a group that had at least 70% efficacy. I'm not sure why 70% is the cutoff, I know it is when drug are approved. But if you are improving say even 50% of the lives of people staying on mono and the other 50% go back safety to haart, then it is only a gain.

Anyway, the FDA letter to CYDY stated 70%. They have that or higher with 525mg and 700mg when randomly assigned. So honestly I don't know why they even need an additional pivotal trial for mono. I could see the FDA wanting more safety data for mono at 700mg and 525mg (normal p3 trials approved has 500-1000 patients) and they have around 300, so I could see requesting addition patients for safety, but the efficacy requirement the FDA requested looks to be already met even before the new trial with the overlap and density test is added. But maybe that is why the FDA stated in their letter they intend to have mono approved, they just want the correct dose determined and possibly the extra patients for safety. We will see what the new mono pivotal trial looks like after the FDA meeting.



(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us